Dow Up 0.48% Nasdaq Up 0.43%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
9.55 0.23(2.47%) Aug 19, 4:00PM EDT
Prev Close:9.32
Open:9.51
Bid:9.20 x 1000
Ask:9.73 x 1300
1y Target Est:7.33
Beta:0.53
Next Earnings Date:N/A
Day's Range:9.35 - 9.75
52wk Range:7.38 - 10.21
Volume:3,695,310
Avg Vol (3m):2,161,430
Market Cap:1.53B
P/E (ttm):5.50
EPS (ttm):1.74
Div & Yield:0.60 (6.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 2.47%1.53B
AMGN101.04B
SGEN5.34B
XOMA470.07M

Key Statistics

Forward P/E (1 yr):4.68
P/S (ttm):3.05
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.06
Quarterly EPS Est (Sep-14) :0.47
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback